Acasti Pharma Presents CaPre Clinical Data at National Lipid Association Scientific Sessions May 18, 2017
Acasti Granted Additional Composition & Use Patents in Taiwan and Australia; Safeguards Valuable Market Expansion Opportunities Apr 24, 2017
Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association Scientific Sessions Apr 12, 2017
Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular Disease Experts Mar 8, 2017
Acasti Pharma Announces Proposed Private Placement of Convertible Debentures and Amended Proposed Offering of Units Feb 2, 2017